Individual #00416869

ID_report AB685 (Family 1)
Reference PubMed: Maltese 2017
Remarks family 1, individual A8685 (proband), 2 generation family, 2 affected
Gender M
Consanguinity -
Country Italy
Population Italian
Age at death -
VIP -
Data_av -
Treatment pars plana vitrectomy, laser photocoagulation
Panel size 1
Diseases EVR, OPPG
Owner name LOVD
Database submission license Creative Commons Attribution 4.0 InternationalCreative Commons License
Created by Anna Tracewska
Date created 2022-09-08 21:04:11 +02:00 (CEST)
Date last edited 2022-09-09 10:36:16 +02:00 (CEST)


Phenotypes

osteoporosis-pseudoglioma syndrome (OPPG) (OPPG)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000308379 familial exudative vitreoretinopathy stage 5 right eye 4B left eye (HP:0030490), osteopenia (HP:0000938); early onset nystagmus with severe retinopathy and rapid development of retinal detachment in the left eye; 1y: pars plana vitrectomy and Argon laser photocoagulation in the right eye for stage 4B familial exudative vitreoretinopathy (retinal detachment involving the macula with falciform fold anchored in the temporal retinal sector and abnormal peripheral exudation); left eye was too advanced due to stage 5 familial exudative vitreoretinopathy (closed funnel retinal detachment); 3y: cataract surgery with intraocular lens implant resulting in stable visual acuity of 0.6 LogMAR in the right eye for the next 3 years; 7y: sudden visual loss (1.0 LogMAR) fluorangiography: retinal exudation next to the falciform fold in the macular area, underwent retinal cryotreatment; subsequent examination showed reabsorption of the exudates and no signs of angiographic leakage; visual acuity restored to 0.6 LogMAR; total X-ray examination of the proband showed thin, elongated diaphyses of the long bones with relatively wider metaphyses, valgus deviation of the femoral neck- diaphysis axis, evident reduction in calcium tone and no other skeletal alterations; dual energy X-ray absorptiometry (DXA): L1 to L4 bone mineral density as 0.4 g/cm2 (Z-score: -1.8); familial exudative vitreoretinopathy stage right/left eye: 4B/5; bone mineral density: osteopenia - osteoporosis-pseudoglioma syndrome (OPPG) Familial 07y 01y - - - LOVD



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000418151 DNA SEQ blood anna_tracewska FZD4, LRP5, NDP, TSPAN12 2 LOVD



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Predicted     

Type/DNA     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
11 Paternal (confirmed) +/. - pathogenic g.68125237A>C g.68357769A>C LRP5 c.608A>C, p.(Asp203Ala) - LRP5_000273 heterozygous PubMed: Maltese 2017 - - Germline yes - - - - LOVD LRP5 - - - - - NM_002335.4:c.608A>C - r.(?) p.(Asp203Ala) - - - - - - - - -
11 Maternal (confirmed) +/. - pathogenic g.68174023dup g.68406555dup LRP5 c.1833dupG, p.(Cys612Valfs*25) - LRP5_000315 heterozygous PubMed: Maltese 2017 - - Germline yes - - - - LOVD LRP5 - - - - - NM_002335.4:c.1833dupG - r.(?) p.(Cys612Valfs*25) - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.